New City, NY, United States of America

Brent M Lok

This inventor holds 62 USPTO granted patents, primarily in Molecular Sieves (CPC class 2081). Top assignees: Union Carbide Corporation, Uop Lcc. Active years: 1978-1992.


% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 19

Forward Citations = 2,375(Granted Patents)

Forward Citations (Not Self Cited) = 2,191(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Spring Valley, NY (US) (1978)
  • Ridgefield, CT (US) (1988)
  • New York, NY (US) (1982 - 1991)
  • New City, NY (US) (1981 - 1992)
  • Shanghai, CN (1992)

Company Filing History:


Years Active: 1978-1992

Loading Chart...
Areas of Expertise:
Molecular Sieves
Titanium-Aluminum
Silicon-Oxide
Catalysts
Hydrocarbon Conversions
Aluminophosphates
Boron-Silicon-Oxide
Gallium-Phosphorus
Crystalline Metallophosphates
Zinc-Aluminum
Iron-Titanium
Cobalt-Aluminum
62 patents (USPTO):Explore Patents

Title: The Inventor Brent M Lok

Introduction: Brent M Lok is a renowned inventor based in New City, NY, known for his groundbreaking contributions to various fields.

Latest Patents: Brent Lok's latest patents include innovative designs in the tech and healthcare industries, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his career, Brent Lok has consistently pushed the boundaries of innovation, with a focus on creating solutions that improve people's lives. His work has been recognized globally for its impact and ingenuity.

Collaborations: Brent Lok has collaborated with leading companies and research institutions to bring his inventions to life, demonstrating his ability to work across disciplines and industries seamlessly.

Conclusion: Brent M Lok's dedication to innovation and his passion for creating meaningful change make him a standout figure in the world of inventors. His work continues to inspire and shape the future of technology and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…